• Sign In
  • Sign Out
  • My Account
Subscribe
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
  • Special reports
Clarivate
  • Data Snapshots
  • BioWorld
  • BioWorld MedTech
  • Infographics: Dynamic digital data analysis
  • Special reports
  • Infographics: Dynamic digital data analysis
  • Trump administration impacts
  • Biopharma M&A scorecard
  • BioWorld 2024 review
  • BioWorld MedTech 2024 review
  • BioWorld Science 2024 review
  • Women's health
  • China's GLP-1 landscape
  • PFA re-energizes afib market
  • China CAR T
  • Alzheimer's disease
  • Israel
  • Rise of obesity
  • Radiopharmaceuticals
  • Biosimilars
  • Aging
  • IVDs on the rise
  • Coronavirus
  • Artificial intelligence

BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
    • Infographics: Dynamic digital data analysis
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Biopharma M&A scorecard
    • BioWorld 2024 review
    • BioWorld MedTech 2024 review
    • BioWorld Science 2024 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Israel
    • Rise of obesity
    • Radiopharmaceuticals
    • Biosimilars
    • Aging
    • IVDs on the rise
    • Coronavirus
    • Artificial intelligence

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
Home » Authors » Omar Ford

Articles by Omar Ford

Through the Looking Glass: Part 1 of 3: Google Glass to impact healthcare landscape in five important ways

Nov. 25, 2014
By Omar Ford
Nearly two and a half years ago, Google (Menlo Park, California) revealed its intention to become a dominant player in the wearable technologies market with the introduction of Project Glass – an effort that would start the path to the creation of Google Glass. Leading off with the mission statement – "We think technology should work for you – to be there when you need it and get out of your way when you don't," the company focused on changing the paradigm of how the public could conceivably access data.
Read More

Cesca files for IDE application for no-option critical limb ischemia

Nov. 24, 2014
By Omar Ford

MDD's Diagnostics Extra

Nov. 21, 2014
By Omar Ford

CombiMatrix enters into IVF market with launch of CombiPGS test

Nov. 19, 2014
By Omar Ford

Personal Genome Diagnostics launches targeted gene panel

Nov. 17, 2014
By Omar Ford

Exactech's Octane Elevate offers safer, more refined implant placement

Nov. 14, 2014
By Omar Ford

Medicrea receives FDA clearance for patient-specific spinal rod

Nov. 13, 2014
By Omar Ford

Orthofix launches clinical study to evaluate use of PEMF technology

Nov. 12, 2014
By Omar Ford
Orthofix (Lewisville, Texas) is reporting the launch of a large-scale clinical study to evaluate the use of pulsed electromagnetic fields (PEMF) technology to see if the therapy can improve osteogenesis (bone growth) in Type II odontoid fractures. More specifically, the study will examine the safety and effectiveness of PEMF treatment with the Orthofix Cervical-Stim device as an adjunct to standard immobilization with a rigid collar.
Read More

NewCo on the Go: Sentrian seeks to make sense of biometric sensors in patient monitoring

Nov. 11, 2014
By Omar Ford
A newly launched company is trying its hand at eliminating unnecessary hospitalizations and better insight on patient deterioration. Sentrian (Aliso Viejo, California) is developing the Remote Intelligence Patient Platform – a software application that could quite possibly help garner greater insight on the health of the patient.
Read More

Data from Shockwave Medical's DISRUPT PAD bodes well for firm

Nov. 10, 2014
By Omar Ford
Shockwave Medical (Fremont, California), a company that specializes in the treatment of peripheral and coronary vascular disease, reported positive clinical results from DISRUPT PAD, a single-arm multi-center study evaluating the safety and utility of Lithoplasty balloon catheters for the treatment of peripheral artery disease, at the Vascular Interventional Advances (VIVA) Annual Conference in Las Vegas.
Read More
Previous 1 2 … 71 72 73 74 75 76 77 78 79 … 227 228 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for May 9, 2025.
  • Today's news in brief

    BioWorld MedTech
    BioWorld MedTech briefs for May 9, 2025.
  • US flag, stock market chart, White House

    100 days of uncertainty

    BioWorld
    The first 100 days of the Trump administration have been nothing short of chaotic, both in the U.S. and throughout the world. Shining a light through the...
  • AI generated, 3D rendering of protein degradation

    AACR 2025: Induced proximity strategy, beyond degraders

    BioWorld
    Targeted protein degradation has yet to notch its first approval. But with more than two dozen agents now in clinical trials, the strategy’s ultimate clinical...
  • NME Digest: Q1 2025

    BioWorld
    A quarterly dynamic table featuring new molecular entities (NMEs) revealed for the first time in current literature, at congresses and in company communications...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld MedTech
    • Today's news
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/Metabolic
    • Immune
    • Infection
    • Neurology/Psychiatric
    • Patents
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2025. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing

BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
    • Infographics: Dynamic digital data analysis
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Biopharma M&A scorecard
    • BioWorld 2024 review
    • BioWorld MedTech 2024 review
    • BioWorld Science 2024 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Israel
    • Rise of obesity
    • Radiopharmaceuticals
    • Biosimilars
    • Aging
    • IVDs on the rise
    • Coronavirus
    • Artificial intelligence

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe